Charity Accounts Intelreading the accounts so you don’t have to

STRUCTURAL GENOMICS CONSORTIUM

Registered charity 1097737 · accounts filings on the Charity Commission register

Enabling the future therapeutic relief of human suffering through genome-scale structural chemistry research.The Charity aims to provide open access to research in structural genomics, structural chemistry and computational chemistry as it relates to the improvement of human health.

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · website · Get email alerts

Latest income
£4.7m
Latest spending
£5.1m
Registered
2003
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity reported a net expenditure of £415,000 for the year, with unrestricted reserves declining to £1,909,000. The trustees confirm the entity is a going concern, citing approved funding applications expected to be completed by November 2025. The charity operates on a five-year funding cycle and aims to break even at the end of the current period.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Largest income source: Bill & Melinda Gates Foundation (69% of income)
“The majority of the income, US$3,261,000, was from the Bill & Melinda Gates Foundation” — page 8
Per its FY2025 accounts as filed with the Charity Commission.
Reserves policy: sufficient funds in reserve to cover its grant commitments for this period to break-even at the end of the period (held: £1.9m)
“aims to keep sufficient funds in reserve to cover its grant commitments for this period to break-even at the end of the period as achieved in previous phases.” — page 9
Per its FY2025 accounts as filed with the Charity Commission.
Payments to trustees: Chair remuneration £10,000
“Remuneration was payable to the Chair of the Board during the year, in relation to her responsibilities as Chair, amounting to £10,000 (2024: £10,000).” — page 24
Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by CT Audit Limited. Discloses 5 of 6 completeness components.

Corporate structure

Leadership, per the charity’s website

Listed on the charity’s own website when we last crawled it; roles may have changed. Pay-band disclosures above are anonymous statutory disclosures and are not attributed to any named individual.

Funders the charity credits

Named as funders/supporters on the charity’s own website (the charity’s claim, distinct from accounts-verified grants).

Company officers (Companies House)

Current officers of the charity’s own company per the Companies House register, cross-checked against the Charity Commission trustee list by name. A director not on the trustee list is usually a timing or naming difference between the two registers — check both records before drawing conclusions.

Official officers record.

Structured financials (annual return, FY ending 30/06/2025)

Total income
£4.7m
Total spending
£5.1m
Reserves (reported)
£3.5m
Employees
0

Reported reserves equal ~8.1 months of spending — above the median for charities its size (median 4.8 months; benchmarks).

Per its annual return, largest income source: Donations and legacies (100% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 0.0% of total income — below the median for charities its size (5.2%) (benchmarks).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Canada · Germany · Japan · Sweden · Switzerland · Throughout England And Wales · United States

Income and spending

Financial year endIncomeSpending
30/06/2025£4.7m£5.1m
30/06/2024£14k£2.4m
30/06/2023£0£4.0m
30/06/2022£4.8m£3.6m
30/06/2021£10.3m£8.5m

Common questions

Is STRUCTURAL GENOMICS CONSORTIUM financially healthy?

Per its FY2025 accounts: The accounts state that the charity reported a net expenditure of £415,000 for the year, with unrestricted reserves declining to £1,909,000. The trustees confirm the entity is a going concern, citing approved funding applications expected to be completed by November 2025. The charity operates on a five-year funding cycle and aims to break even at the end of the current period. Its FY2025 accounts were audited by CT Audit Limited.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

FunderSimilar charities fundedAmount to them
HEALTH DATA RESEARCH UK1£2.2m
THE KENNEL CLUB CHARITABLE TRUST1£120k
ALZHEIMER'S RESEARCH UK1£69k
JUVENILE DIABETES RESEARCH FOUNDATION LIMITED1£38k

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with GENOME RESEARCH LIMITED.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
STRUCTURAL GENOMICS CONSORTIUM£4.7m—0unclear—no doubt
GENOME RESEARCH LIMITED FY2025£180.3m——unclear—no doubt
THE LORNA AND YUTI CHERNAJOVSKY BIOMEDICAL RESEARCH FOUNDATION FY2025£508k—0above—no doubt
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE FY2024£9.9m£310,001 - £320,000—below—no doubt
THE CANCER TREATMENT AND RESEARCH TRUST CIO FY2024£502k—0above—no doubt
STOCKPORT NHS FOUNDATION TRUST GENERAL FUND FY2025£930k—0above—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.